Market Indices
Sector Heatmap
MLYS — Mineralys Therapeutics, Inc. Common Stock
NasdaqMineralys Therapeutics, Inc. Common Stock
- O
- 23.54
- H
- 23.54
- L
- 21.88
- V
- 1.21M
MLYS — Latest News & Headlines
15 StoriesTwo new hires at Mineralys receive options on 46,430 shares and stock awards tied to 34,823 shares. - Stock Titan
Two new hires at Mineralys receive options on 46,430 shares and stock awards tied to 34,823 shares. Stock Titan
Will AHA Trial Data Change Mineralys Therapeutics (MLYS) Narrative - Simply Wall Street
Will AHA Trial Data Change Mineralys Therapeutics (MLYS) Narrative Simply Wall Street
Understanding the Setup: (MLYS) and Scalable Risk - Stock Traders Daily
Understanding the Setup: (MLYS) and Scalable Risk Stock Traders Daily
A Sept. 30 fireside chat with Mineralys management will stream live at noon ET. - Stock Titan
A Sept. 30 fireside chat with Mineralys management will stream live at noon ET. Stock Titan
How Investors Are Reacting To Mineralys Therapeutics (MLYS) Long Term Blood Pressure Data - Simply Wall Street
How Investors Are Reacting To Mineralys Therapeutics (MLYS) Long Term Blood Pressure Data Simply Wall Street
Mineralys Grants Equity Awards to New Employees - MyChesCo
Mineralys Grants Equity Awards to New Employees MyChesCo
A sleep apnea trial of a blood pressure drug will be presented at a heart meeting. - Stock Titan
A sleep apnea trial of a blood pressure drug will be presented at a heart meeting. Stock Titan
Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com India
Mineralys Therapeutics director sells $3 million in shares By Investing.com Investing.com India
Mineralys Therapeutics (MLYS) In Focus As Lorundrostat Data Nears Fair Value Debate - Simply Wall Street
Mineralys Therapeutics (MLYS) In Focus As Lorundrostat Data Nears Fair Value Debate Simply Wall Street
Long-term results for a blood pressure drug will be presented at an American Heart Association meeting - Stock Titan
Long-term results for a blood pressure drug will be presented at an American Heart Association meeting Stock Titan
A fund sold Mineralys (MLYS) shares and still holds more than 7.8 million. - Stock Titan
A fund sold Mineralys (MLYS) shares and still holds more than 7.8 million. Stock Titan
A 75,000-share sale is proposed by a Mineralys (MLYS) officer and director. - Stock Titan
A 75,000-share sale is proposed by a Mineralys (MLYS) officer and director. Stock Titan
After a CEO share sale, 528,621 shares remain with Mineralys Therapeutics (MLYS) chief. - Stock Titan
After a CEO share sale, 528,621 shares remain with Mineralys Therapeutics (MLYS) chief. Stock Titan
Mineralys Stock Sinks as Losses and Insider Sales Bite - TipRanks
Mineralys Stock Sinks as Losses and Insider Sales Bite TipRanks
Mineralys Soars As Hypertension Drug Nears Key Decision - TipRanks
Mineralys Soars As Hypertension Drug Nears Key Decision TipRanks